{{Rsnum
|rsid=13393577
|Gene=ERBB4
|Chromosome=2
|position=212432139
|Orientation=plus
|GMAF=0.09275
|Gene_s=ERBB4
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 0.9 | 19.8 | 79.3
| HCB | 0.0 | 7.3 | 92.7
| JPT | 0.0 | 12.4 | 87.6
| YRI | 1.4 | 18.4 | 80.3
| ASW | 1.8 | 28.1 | 70.2
| CHB | 0.0 | 7.3 | 92.7
| CHD | 0.0 | 5.5 | 94.5
| GIH | 4.0 | 20.8 | 75.2
| LWK | 1.8 | 26.4 | 71.8
| MEX | 0.0 | 17.2 | 82.8
| MKK | 1.3 | 16.8 | 81.9
| TSI | 0.0 | 19.6 | 80.4
| HapMapRevision=28
}}{{PMID Auto
|PMID=22452962
|Title=A genome-wide association study identifies a breast cancer risk variant in ERBB4 at 2q34: results from the Seoul Breast Cancer Study
|OA=1
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | Illumina Human 1M}}